Clinical characteristics of 39 patients with systemic lupus erythematosus and antiphospholipid syndrome
10.3760/cma.j.issn.1008-6315.2010.07.027
- VernacularTitle:系统性红斑狼疮合并抗磷脂综合征患者的临床分析
- Author:
Shaokun WANG
;
Weiling YUAN
;
Ying LIU
- Publication Type:Journal Article
- Keywords:
Systemic lupus erythematosus;
Antiphospholipid syndrome;
Anticardiolipin antibody
- From:
Clinical Medicine of China
2010;26(7):746-748
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the clinical characteristics of systemic lupus erythematosus with Antiphospholipid syndrome (SLE-APS).Methods The clinical data of 39 cases of SLE-APS were collected and analyzed retrospectively. Results Thirty-one patients had 48 thrombosis episodes in total, among which the most common presenting manifestations were deep venous thrombosis and stroke. 12 of 26 married women had fetal morbidity. The prevalence of anticardio lipin antibody (aCL) and lupus anticoagulant ( LA) was 72% and 41% , respectively. 24 patients had SLE at first,on an average of 9. 5 years later they had the characteristics of APS, 12 patients had thrombosis episodes or fetal morbidities ,4. 8 years later they developed into SLE,and 3 patients had the characteristics of SLE and APS from the onset The SLEDAI was less than 5 in five cases when they had thrombosis episodes or fetal morbidities.Conclusions The incidence of thrombosis episodes or fetal morbidities increased in SLE-APS patients. APS occurred before, after or at the same time with SLE. SLE patients might have the clinical features of APS during the steady stage. It's very important to ask the medical history in detail and measure aCL in lupus patients to find the risk factor of APS and prevent the APS' occurrence.
